Key indicators: single-crystal X-ray study; T = 293 K; mean (C-C) = 0.002 Å; R factor = 0.033; wR factor = 0.092; data-to-parameter ratio = 13.3.
In the title compound, C 22 H 22 ClN 3 O 4 , the cyclohexane ring adopts a twisted half-chair conformation. The molecule is stabilized by an intramolecular O-HÁ Á ÁN interaction, generating an S(6) motif. The crystal packing is stabilized by intermolecular O-HÁ Á ÁN and C-HÁ Á ÁO interactions.
Related literature
For the synthesis and stereochemistry investigations through NMR of N(2)-pyridyl tetrahydroindazoles, see: Amirthaganesan et al. (2008) . For the biological activity of tetrahydroindazoles, see: Connolly et al. (1997) . For ring conformational analysis, see: Cremer & Pople (1975); Nardelli (1983) .
Experimental
Crystal data Table 1 Hydrogen-bond geometry (Å , ). Ethyl 4-(3-chlorophenyl)-3,6-dihydroxy-6-methyl-2-(2-pyridyl)-4,5,6,7-tetrahydroindazole-5-carboxylate S. Amirthaganesan, G. Aridoss, D.Gayathri, K. S. Park and Y. T. Jeong
Comment
In azole family, tetrahydroindazoles (cycloalkane derivatives of pyrazoles) are having much importance for their effective biological potencies (Connolly et al., 1997) . Our current research work is focused on the stereospecific synthesis of 1 (H) and various N-substituted tetrahydroindazoles by taking cyclic β keto esters as an effective synthons, and exploring their stereochemistry. Recently, we have described complete structural elucidation and conformation of a series of N(2)-pyridyl tetrahydroindazoles (Amirthaganesan et al., 2008) . One and two dimensional NMR investigations strongly proved that all the compounds obtained as a single isomer where cyclohexane ring adopts slightly distorted chair conformation and pyridyl moiety favored at N(2) position in the azole ring. We report here the X-ray crystal structure of the title compound. h. After completion of the reaction, the solvent was evaporated under vacuum and the resultant residue was recrystallized from ethanol.
Refinement
All H-atoms were refined using a riding model with d(C-H) = 0.93 Å, U iso = 1.2U eq (C) for aromatic, 0.98 Å, U iso = 1.2U eq (C) for CH, 0.97 Å, U iso = 1.2U eq (C) for CH 2 0.96 Å, U iso = 1.5U eq (C) for CH 3 atoms and d(O-H) = 0.82 Å, U iso (H) = 1.5U eq (O) for the OH group.
supplementary materials sup-2 Figures   Fig. 1 . The molecular structure of title compound, showing 30% probability displacement ellipsoids. Fig. 2 . The molecular packing of (I). For clarity, hydrogen atoms which are not involved in hydrogen bonding are omitted.
Ethyl 4-(3-chlorophenyl)-3,6-dihydroxy-6-methyl-2-(2-pyridyl)-4,5,6,7-tetrahydroindazole-5-carboxylate
Crystal data 
Special details
Geometry. All esds (except the esd in the dihedral angle between two l.s. planes) are estimated using the full covariance matrix. The cell esds are taken into account individually in the estimation of esds in distances, angles and torsion angles; correlations between esds in cell parameters are only used when they are defined by crystal symmetry. An approximate (isotropic) treatment of cell esds is used for estimating esds involving l.s. planes. 
Refinement. Refinement of F

